SignatureFD’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$88.9K Hold
4,145
﹤0.01% 1516
2026
Q1
$57.5K Sell
4,145
-1,621
-28% -$25.8K ﹤0.01% 1652
2025
Q4
$93.6K Sell
5,766
-3
-0.1% -$49 ﹤0.01% 1353
2025
Q3
$86.3K Buy
5,769
+1,176
+26% +$14.3K ﹤0.01% 1370
2025
Q2
$53.5K Buy
4,593
+86
+2% +$781 ﹤0.01% 1547
2025
Q1
$33.5K Hold
4,507
﹤0.01% 1789
2024
Q4
$27K Hold
4,507
﹤0.01% 1907
2024
Q3
$23.1K Buy
4,507
+388
+9% +$1.69K ﹤0.01% 1969
2024
Q2
$14.9K Buy
4,119
+525
+15% +$1.67K ﹤0.01% 2101
2024
Q1
$11.5K Buy
3,594
+8
+0.2% +$31 ﹤0.01% 2250
2023
Q4
$17.6K Buy
3,586
+514
+17% +$2.35K ﹤0.01% 1982
2023
Q3
$16.7K Sell
3,072
-118
-4% -$780 ﹤0.01% 1940
2023
Q2
$21.4K Buy
3,190
+2,579
+422% +$19.2K ﹤0.01% 1852
2023
Q1
$5.39K Sell
611
-104
-15% -$917 ﹤0.01% 2480
2022
Q4
$5.46K Buy
715
+623
+677% +$4.85K ﹤0.01% 2437
2022
Q3
$1K Buy
+92
New +$866 ﹤0.01% 2894
2020
Q3
Sell
-45
Closed -$2K 2588
2020
Q2
$2K Buy
+45
New +$1.64K ﹤0.01% 2068

Other funds holding ADPT

SignatureFD's ADPT Position: Q2 2026 in Review

SignatureFD held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 4,145 shares worth $88.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1516.

SignatureFD first reported a position in ADPT in Q2 2020 and has held it in 17 quarters since. The position peaked at $93.6K in Q4 2025. 40 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • SignatureFD held 4,145 shares of Adaptive Biotechnologies worth $88.9K as of Q2 2026.
  • SignatureFD left its Adaptive Biotechnologies share count unchanged in Q2 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1516 holding.
  • SignatureFD first reported a position in Adaptive Biotechnologies in Q2 2020 and has held it in 17 quarters since.
  • SignatureFD's Adaptive Biotechnologies position peaked at $93.6K in Q4 2025.
  • 40 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.